Skip navigation
Home
News
Products
about IR-World
Team
Customers
Partner
Contact
DE
EN
Communicators
are winners!
Text der Meldung
More News
24.10.2019
Sernova Announces Biotech Veteran as New Chief Financial Officer
16.10.2019
Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes
26.07.2019
Sernova Announces Up to $3 Million Private Placement Financing
17.07.2019
Sernova's Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data
23.07.2018
Sernova Completes Oversubscribed Private Placement of $2,754,000
16.07.2018
Sernova Announces $2,000,000 First Closing of Private Placement Due to Oversubscription, Offering Increased to $2,700,000
05.07.2018
Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes
14.05.2018
Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch Clinical Study
08.05.2018
Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator
26.01.2016
Sernova Announces Agreement with CCRM to Produce Specialized Cells for the Treatment of Diabetes
First
Previous
4
5
6
7
8
9
10
Next